| AMI | acute myocardial infarction |
| apoA1 | apolipoprotein A1 |
| apoB | apolipoprotein B-100 |
| apoM | apolipoprotein M |
| apo(a) | apolipoprotein small a |
| CVD | cardiovascular diseases |
| ELISA | enzyme-linked immunosorbent assay |
| FH | familial hypercholesterolemia |
| HDL | high-density lipoprotein |
| LCAT | lecithin-cholesterol acyltransferase |
| LC-MS/MS | liquid chromatography-tandem mass spectrometry |
| LDL | low-density lipoprotein |
| LDL(−) | electronegative low-density lipoprotein |
| LOX-1 | lectin-like oxidized low-density lipoprotein receptor-1 |
| Lp(a) | lipoprotein small a |
| Lp-PLA2 | lipoprotein associated phospholipase A2 |
| mAb | monoclonal antibody |
| MCP-1 | monocyte chemoattractant protein-1 |
| MM-LDL | minimally modified low-density lipoprotein |
| MPO | myeloperoxidase |
| NETs | neutrophils extracellular traps |
| NF-kB | nuclear factor-kappa binding protein |
| oxHDL | oxidized high-density lipoprotein |
| oxLDL | oxidized low-density lipoprotein |
| oxPC | oxidized phosphatidylcholine |
| PC | phosphatidylcholine |
| PON1 | paraoxonase-1 |
| PTCA | percutaneous transluminal coronary angioplasty |
| PUFA | polyunsaturated fatty acid |
| sdLDL | small dense low-density lipoprotein |
| SR-A | scavenger receptor type A |
| STEMI | ST-elevation myocardial infarction |
| TBARS | thiobarbituric acid reactive substances |
| TG | triacylglycerol |
| WHHL | Watanabe heritable hyperlipidemic |